RSPH14 and hepatocellular carcinoma: Furthermore, data from the metastasis assay showed that the knockdown of RSPH14 significantly suppressed the metastatic capability of HCC cells (Fig. 6A, B; Supplementary Figure S4C, D), as well as stemness and resistance to lenvatinib (Fig. 6C, D).